You have 9 free searches left this month | for more free features.

sgi-110

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia Trial in Kyoto, Region (SGI-110)

Completed
  • Acute Myeloid Leukemia
  • SGI-110
  • Kyoto, Japan
  • +2 more
Feb 12, 2021

Metastatic Colorectal Cancer Trial in Baltimore (CY, GVAX, SGI-110)

Completed
  • Metastatic Colorectal Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 26, 2021

MDS, CMML, AML Trial in Canada, United States (SGI-110)

Completed
  • MDS
  • +2 more
  • SGI-110
  • Scottsdale, Arizona
  • +15 more
Apr 16, 2021

Previously Treated Metastatic Colorectal Cancer Trial in Netherlands, United States (SGI-110 Dose Escalation, Regorafenib,

Completed
  • Previously Treated Metastatic Colorectal Cancer
  • SGI-110 Dose Escalation
  • +4 more
  • Los Angeles, California
  • +3 more
Sep 14, 2020

Ovarian Cancer Trial in Canada, United Kingdom, United States (SGI-110, Treatment of Choice (topotecan, pegylated liposomal

Completed
  • Ovarian Cancer
  • SGI-110
  • +2 more
  • Los Angeles, California
  • +23 more
Apr 30, 2021

Hepatocellular Carcinoma Trial in Canada, United Kingdom, United States (SGI-110)

Completed
  • Hepatocellular Carcinoma
  • SGI-110
  • Duarte, California
  • +23 more
Jan 13, 2020

Extensive-stage Small Cell Lung Cancer Trial in New York (Durvalumab, Tremelimumab, SGI-110)

Completed
  • Extensive-stage Small Cell Lung Cancer
  • New York, New York
    Columbia University Medical Center
Dec 7, 2018

Metastatic Melanoma Trial in Siena (SGI-110, Ipilimumab)

Unknown status
  • Metastatic Melanoma
  • Siena, Italy
    Medical Oncology and Immunotherapy Unit, University Hospital of
Nov 16, 2015